Lo.Li. Pharma, Ltd.   Report issue

For profit Phase 4
Founded: Rome Italy (2010)
Status: No NME R&D (2010)

Organization Overview

First Clinical Trial
2011
NCT01290432
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Lo.Li.Pharma s.r.l

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infertility (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 15
  • # of Trial APIs: 15